,13 By activating proteasomal degradation of IKZF1 and IKZF3, coupled with immunomodulatory effects, inhibition of angiogenesis, and disruption of MM cells with bone marrow stroma, pomalidomide exhibits potent anti-MM activity.11 This evidence concerns the gene IKZF3 and Miyoshi myopathy.